This decline may reflect various possibilities, including: (1) Tumor cells may downregulate calreticulin in the lumen of the endoplasmic reticulum, (2) dying cells that have expressed calreticulin on the surface may have been cleared by the immune system after 24 h, resulting in a lower percentage of positive cells. This evidence concerns the gene CALR and neoplasm.